ICON plc
(NASDAQ : ICLR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 3.03%61.940.0%$779.50m
VRXValeant Pharmaceuticals International, Inc. -2.07%28.8614.1%$169.82m
CTLTCatalent, Inc. 0.28%141.412.0%$168.28m
PRGOPerrigo Co. Plc 0.55%43.016.9%$140.02m
ICLRICON plc 0.56%283.042.8%$122.12m
HZNPHorizon Therapeutics Plc 0.80%110.375.5%$106.97m
JAZZJazz Pharmaceuticals Plc 0.63%135.352.1%$104.94m
INDPIndaptus Therapeutics, Inc. -6.86%8.820.0%$101.49m
ARGXargenx SE -3.15%308.000.0%$64.03m
BHCBausch Health Cos., Inc. -2.07%28.860.0%$60.89m
ENDPEndo International Plc -3.85%3.258.5%$56.03m
UTHRUnited Therapeutics Corp. -2.68%195.1014.0%$46.59m
AXSMAxsome Therapeutics, Inc. 1.34%33.401.8%$38.98m
IRWDIronwood Pharmaceuticals, Inc. 3.54%13.459.5%$24.56m
SAGESAGE Therapeutics, Inc. -1.69%45.427.6%$21.56m

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.